Studies of bladder stone disease in Thailand. XVI. Effect of 4-hydroxy-L-proline and orthophosphate supplementations on urinary composition and crystalluria.
D002118:Calcium / Q000652:urine; D003404:Creatinine / Q000652:urine; D006801:Humans; D006909:Hydroxyproline / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use / Q000652:urine; D007223:Infant; D007227:Infant Nutritional Physiological Phenomena; D007677:Kidney Function Tests; D008297:Male; D010070:Oxalates / Q000652:urine*; D010710:Phosphates / Q000494:pharmacology* / Q000627:therapeutic use; D010758:Phosphorus / Q000652:urine; D011188:Potassium / Q000494:pharmacology / Q000627:therapeutic use; D012964:Sodium / Q000494:pharmacology / Q000627:therapeutic use; D013785:Thailand; D013997:Time Factors; D001744:Urinary Bladder Calculi / Q000453:epidemiology / Q000517:prevention & control* / Q000652:urine; D014556:Urine
D010070:Oxalates; D010710:Phosphates; D010758:Phosphorus; D012964:Sodium; D003404:Creatinine; D006909:Hydroxyproline; D011188:Potassium; D002118:Calcium